Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel.

Joshua BurshteinDanny ZakriaBrian BermanSeemal R DesaiAaron S FarbergGary GoldenbergBrad GlickMark NestorKeyvan NouriTheodore RosenMark LebwohlDarrell Rigel

Published in: Journal of drugs in dermatology : JDD (2024)

The 2-GEP test and EIS can aid in the precise diagnosis of clinically indeterminate lesions and the 23-GEP test can be used when histopathology is equivocal. The 31-GEP test can enhance prognostic assessment beyond AJCC8 staging and improve clinical decision-making. J Drugs Dermatol. 2024;23(9):774-781. doi:10.36849/JDD.8365R1.

Keyphrases

decision making
lymph node